EHA Library - The official digital education library of European Hematology Association (EHA)

MAGIC-TT-MEDIATED CELLS TARGET TRANSPLANTATION INTO BONE MARROW WHICH INCLUDES THE STUDY OF CELL DISTRIBUTION IN VIVO AND THE EFFECTS OF HEMATOPOIETIC RECONSTRUCTION.
Author(s): ,
Hao Huang
Affiliations:
Nanfang Hospital,Guangzhou,China
,
Qianli Jiang
Affiliations:
Nanfang Hospital,Guangzhou,China
,
Yongjun Zhou
Affiliations:
Nanfang Hospital,Guangzhou,China
,
Qiuxia Zhang
Affiliations:
Nanfang Hospital,Guangzhou,China
,
Xiaowei Sun
Affiliations:
Southern Medical University,Guangzhou,China
,
Minchun Zhang
Affiliations:
Southern Medical University,Guangzhou,China
,
Jing Sun
Affiliations:
Nanfang Hospital,Guangzhou,China
,
Qiusui Mai
Affiliations:
Southern Medical University,Guangzhou,China
,
Zhihao Zheng
Affiliations:
Southern Medical University,Guangzhou,China
,
Yuncong Lu
Affiliations:
Southern Medical University,Guangzhou,China
,
Li Liu
Affiliations:
Southern Medical University,Guangzhou,China
,
Jerry Majaw
Affiliations:
Southern Medical University,Guangzhou,China
,
Ning Gan
Affiliations:
Ningbo University,Ningbo,China
Shan Jiang
Affiliations:
Southern Medical University,Guangzhou,China
(Abstract release date: 05/19/16) EHA Library. Huang H. 06/09/16; 134746; PB1846
Dr. Hao Huang
Dr. Hao Huang
Contributions
Abstract
Abstract: PB1846

Type: Publication Only

Background
Target cell transplantation to bone marrow (BM) is possible by Magnetism-induced cell target transplantation (MagiC-TT) (EHA2015posterP701). 

Aims
RFP-MSC were used to observe the cell’s distribution and the following effect, additionally CD45+ GFP cells were used to evaluate the promotion of hematopoietic reconstitution of MagiC-TT.

Methods
1)Target transplantation of MSC: Fe3O4@PDA@Au nanoparticles (NPs) were synthesized and introduced into Luciferase gene modified RFP-MSC (Luc-RFP-MSCs). Magnetized and wt Luc-RFP-MSCs were compared on the biological feature and their ability of migration ex vivo. Then magnetized RFP-MSCs were micro-injected into the femur cavity of the mice with the help of X-ray (Fig.1a), under magnet in M group or without in W group. Bioluminescence, FACS, PCR and histopathological analysis were ued after transplantation. 20 eGFP transgenic mice and another 20 C57 mice were used. 2) CD45+ cells transplantation: 34 C57 mice were randomly divided into 2 groups evenly. 7.5Gy myeloablative irradiation were given 1d before, then CD45+ cells were isolated by MACS from eGFP transgenic mice and freshly micro-injected into right femur, 1×106 cells/20uL per mouse, with or without magnet for 24hrs (M or W group). At 0h, 24h, 72h after injection, every 3 mice in both groups were sacrificed at each time point for detection, then remaining 8 mice in both groups were compared with the general conditions, hematopoietic recovery, GFP+ cells in different organs etc.

Results
1) Target transplantation of MSCs: NPs exist within or on the surface of magnetized RFP-MSCs (Fig.1b), no obvious change was found. The magnetized RFP-MSCs were capable of target migration under magnetism ex vivo. Bioluminescence assay showed that the magnetized Luc-RFP-MSCs appeared in the lung of W group 5 min after cell injection, while fixed in the femur of M group mice. However, on withdrawal of magnet 1h after cell injection, strong fluorescence was observed in the lung of M group gradually (Fig.1c). By pathological examinations, FACS and PCR, large number of RFP-MSCs were observed to reside within the BM in M group while few in W group, thereby demonstrating the specific BM target transplantation of magnetized RFP-MSCs. Those RFP-MSCs were found to survive more than 3m in different organs. 2) CD45+ cells transplantation: The mice that survived were 7/8 vs 1/8 in M or W group respectively (Fig.1d). The GFP% in femurs of both groups (Tab.1) also proved the specific BM target transplantation in M group. Platelet recovery in M group is faster than that in W group (12.33d±2.42d vs 16.38d±2.39d, P=0.009); and the lowest value of decreased hemoglobin in M group was higher than that of W group (43.75±13.02 vs 13.75±5.18, P<0.001).
Table 1. Comparison of the percentage of RFP-MSCs in M group and W group by flow cytometry.
group0h(%)p24h(%)p72h(%)p
*LC**RTLCRTLCRT
BMM0.017±0.0060.497±0.1510.0400.080±0.0261.573±0.5080.0300.190±0.1391.960±0.8090.049
BMW0.017±0.0120.050±0.0170.1840.013±0.0060.027±0.0150.1840.023±0.0150.320±0.4340.368
P1.0000.007 0.0130.006 0.1080.036 
*:Left control femur; **: Right experimental femur.


Conclusion
Fe3O4@PDA@Au NPs rendered MSCs their capability of target transplantation by MagiC-TT technique. MagiC-TT also helps in the recovery of PLT after transplantation after CD45+ hematopoietic cell transplantation .



Session topic: E-poster

Keyword(s): GFP, HSCT, Nanoparticle, Targeted therapy
Abstract: PB1846

Type: Publication Only

Background
Target cell transplantation to bone marrow (BM) is possible by Magnetism-induced cell target transplantation (MagiC-TT) (EHA2015posterP701). 

Aims
RFP-MSC were used to observe the cell’s distribution and the following effect, additionally CD45+ GFP cells were used to evaluate the promotion of hematopoietic reconstitution of MagiC-TT.

Methods
1)Target transplantation of MSC: Fe3O4@PDA@Au nanoparticles (NPs) were synthesized and introduced into Luciferase gene modified RFP-MSC (Luc-RFP-MSCs). Magnetized and wt Luc-RFP-MSCs were compared on the biological feature and their ability of migration ex vivo. Then magnetized RFP-MSCs were micro-injected into the femur cavity of the mice with the help of X-ray (Fig.1a), under magnet in M group or without in W group. Bioluminescence, FACS, PCR and histopathological analysis were ued after transplantation. 20 eGFP transgenic mice and another 20 C57 mice were used. 2) CD45+ cells transplantation: 34 C57 mice were randomly divided into 2 groups evenly. 7.5Gy myeloablative irradiation were given 1d before, then CD45+ cells were isolated by MACS from eGFP transgenic mice and freshly micro-injected into right femur, 1×106 cells/20uL per mouse, with or without magnet for 24hrs (M or W group). At 0h, 24h, 72h after injection, every 3 mice in both groups were sacrificed at each time point for detection, then remaining 8 mice in both groups were compared with the general conditions, hematopoietic recovery, GFP+ cells in different organs etc.

Results
1) Target transplantation of MSCs: NPs exist within or on the surface of magnetized RFP-MSCs (Fig.1b), no obvious change was found. The magnetized RFP-MSCs were capable of target migration under magnetism ex vivo. Bioluminescence assay showed that the magnetized Luc-RFP-MSCs appeared in the lung of W group 5 min after cell injection, while fixed in the femur of M group mice. However, on withdrawal of magnet 1h after cell injection, strong fluorescence was observed in the lung of M group gradually (Fig.1c). By pathological examinations, FACS and PCR, large number of RFP-MSCs were observed to reside within the BM in M group while few in W group, thereby demonstrating the specific BM target transplantation of magnetized RFP-MSCs. Those RFP-MSCs were found to survive more than 3m in different organs. 2) CD45+ cells transplantation: The mice that survived were 7/8 vs 1/8 in M or W group respectively (Fig.1d). The GFP% in femurs of both groups (Tab.1) also proved the specific BM target transplantation in M group. Platelet recovery in M group is faster than that in W group (12.33d±2.42d vs 16.38d±2.39d, P=0.009); and the lowest value of decreased hemoglobin in M group was higher than that of W group (43.75±13.02 vs 13.75±5.18, P<0.001).
Table 1. Comparison of the percentage of RFP-MSCs in M group and W group by flow cytometry.
group0h(%)p24h(%)p72h(%)p
*LC**RTLCRTLCRT
BMM0.017±0.0060.497±0.1510.0400.080±0.0261.573±0.5080.0300.190±0.1391.960±0.8090.049
BMW0.017±0.0120.050±0.0170.1840.013±0.0060.027±0.0150.1840.023±0.0150.320±0.4340.368
P1.0000.007 0.0130.006 0.1080.036 
*:Left control femur; **: Right experimental femur.


Conclusion
Fe3O4@PDA@Au NPs rendered MSCs their capability of target transplantation by MagiC-TT technique. MagiC-TT also helps in the recovery of PLT after transplantation after CD45+ hematopoietic cell transplantation .



Session topic: E-poster

Keyword(s): GFP, HSCT, Nanoparticle, Targeted therapy

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies